Page 162 - CW E-Magazine (27-8-2024)
P. 162

News from Abroad                                                                                                                                                                  News from Abroad


       COLLABORATION                                                                                                 PRODUCT SAFETY CONCERNS
       Evonik using Knauer’s expertise to improve scale                                                              Clean beauty activist urges US-FDA to ban toxic

       up of lipid nanoparticles formulations                                                                        hair relaxers


                                                                                                                        An open letter from the Clean Beauty                             lungs or when coming into contact with
         Evonik is collaborating with Knauer                              scientifi c instruments used in research
       Wissenschaftliche  Geräte  GmbH,  a                                and commercial applications. Recently,     Action Network (CBAN) has urged US-                                 the eyes or skin.
                                                                                                                     FDA Commissioner Robert Califf to act
       German  manufacturer  of  scientifi c  in-                          Evonik    implemented    Knauer’s          on the agency’s promise to ban toxic hair                              “The big picture here is that most
       struments, to improve the upscaling of                             IJM NanoScaler Pro technology, which       relaxers amid research from the agency                              consumers don’t know that the cos-
       lipid nanoparticle (LNP) formulations.                             addresses the long-standing challenges     that  shows  some  hair  relaxers  contain                          metics and beauty products we use
                                                                          in  nucleic  acid  LNP  formulations  by
         “By  combining  Evonik’s  formula-                               reducing  the  need  for  labour-inten-    formaldehyde,  a  known  carcinogen.                                don’t have to be verifi ed as safe. Peo-
       tion and scale-up expertise with Knauer’s                          sive and time-consuming experiments,       CBAN  founder  Ms.  Daphne  Nguyen                                  ple  are  rightly  shocked  and  appalled
                                                                                                                     said Mr. Califf must immediately prio-
                                                                                                                                                                                         that  our  personal  care  products  con-
       technological  know-how,  customers                                thereby signifi cantly reducing the time    ritise the USFDA rulemaking process on                              tain formaldehyde, asbestos and other
       can  improve  effi ciency  and  increase                            and  material  costs  associated  with     using formaldehyde in hair relaxers.  CBAN, a youth-led nonprofi t organi-  toxic chemicals and carcinogens,” Ms.
       speed  to  market,  signifi cantly  cutting                         screening  for  optimal  LNP  formula-                                       sation aims to make  the cosmetics  Nguyen  said  in  her  letter.  CBAN’s
       the  initial  pre-clinical  development                            tions on platforms that do not necessa-       The  letter  highlighted  the  delayed  industry  a  “safer,  greener  and  more  advocacy refl ects growing concern over
       time,” Evonik said in a press note.  worldwide  with  lipids  and  LNP  drug  rily upscale when introduced into more   rule-making process regarding the ban  ethical landscape” through scientifi c re-  the  underregulated  cosmetics  indus-
                                         product  development  activities.  The  proven IJM large scale systems.
         “Our extensive expertise in chemis-  LNP  market  alone  is  estimated  to  be                              on  formaldehyde  in  hair  smoothing  search, public education and advocacy.  try and the urgent need for regulatory
                                                                                                                                                                                         action to protect consumers from
       try and formulation science has enabled  over $600-mn (up to $1-bn) with conti-  Lipids  are  the  building  blocks  of   and  straightening  products.  Despite   Chemical hair relaxers break down  harmful  chemicals.  The  call  to  ban
                                                                                                                     the  proposed  rule  being  listed  under
       us to capture a signifi cant proportion of  nued  growth  projected  over  the  next  living  cells  and  are  essential  for  the   Regulation  Identifi er  Number  (RIN)  proteins in the hair to straighten it. Ac-  formaldehyde aligns with the broader
       the growing market for mRNA and gene  decade.                      effi cient encapsulation and delivery of    #0910-AI83  and  scheduled  for  public  cording to the USFDA, the formalde-  mission  to  promote  clean  beauty  and
       therapies.  Thanks  to  our  collaboration                         mRNA  and  other  nucleic  acid-based      comment in April 2024, there has been  hyde used in these products presents  ensure  products  are  safe  for  both
       with  Knauer,  we  are  now  even  better   “Together with Knauer, we can in-  drugs.  The  nucleic  acids  are  encased   no progress.         health hazards when breathed into the  people and the planet.
       positioned to offer differentiation op-  crease the speed with which we go from  in an LNP composed of specifi c lipids,
       tions,” said Mr. Yann d’Hervé, head of  very small-scale prototypes to produc-  which not only protects the nucleic acid   LITHIUM MINING
       the Health Care business line at Evonik.  tion-scale  lead  formulations,  and  then  from degradation, but also ensures its
                                         directly  into  GMP  production  of  drug  safe delivery into cells where it can be   Pilbara Minerals set to acquire Latin Resources
         Nucleic acid therapeutics represent  products,” said Ms. Andrea Engel, head  released.  LNPs  have  emerged  as  the
       a huge and expanding proportion of the  of Growth Projects Evonik Health Care.  most  advanced  drug  delivery  system,   Australian  lithium  mining  fi rms  –                   Minerals  shares  upon  implementing
       overall  parental  drugs  market.  Evon-                           highlighted by their role in the global    Pilbara Minerals and Latin Resources –                              the scheme. Based on Pilbara Minerals’
       ik  supplies  pharmaceutical  companies   Knauer  is  known  for  its  high-end  fi ght against COVID-19.      have announced plans to merge. Pilbara                              closing  price  of  $2.85  per  share  on
                                                                                                                     Minerals  has  inked  a  binding  scheme
                                                                                                                                                                                         August 14, 2024, the transaction implies
       DKSH extends distribution deal with Cosucra in                                                                implementation  agreement  (SIA)  to                                a value of $0.20 per Latin share, repre-
       Australia and New Zealand                                                                                     acquire  smaller  peer,  Latin  Resources                           senting a 57% premium to the compa-
                                                                                                                     for  an  implied  value  of  A$559.9-mn
                                                                                                                                                                                         ny’s 10-day volume weighted average
                                                                                                                     ($369.4-mn). As  part  of  the  proposed                            price  of  $0.127  per  share.    Latin
          DKSH  has  expanded  its  exclusive                             for healthy, sustainable, and tasty food   transaction,  Pilbara  Minerals,  which                             Resources’  board  has  unanimously
       distribution agreement with Cosucra, a                             products. Cosucra’s naturally produced,    has a market capitalisation of $8.57-bn,                            recommended  the  deal  in  the  absence
       Belgian producer of natural and healthy                            trademarked ingredient range includes      will  secure  Latin  Resources’  fl agship                           of a better proposal.
       food ingredients, in Australia and New                             Fibrulose and  Fibruline chicory root      Salinas  Lithium  Project,  which  has
       Zealand.                                                           fi bre, Pisane pea protein isolate range,   potential to become a top 10 hard rock                                 Pilbara  Minerals’  CEO  Mr.  Dale
                                                                          as well as Swelite pea fi bre, and Nastar   lithium  operation  by  production  glob-                           Henderson  said  the  acquisition  is
          DKSH’s  performance  materials                                  pea starch.                                ally. The project lies in the Minas Ge-                             on-strategy,  diversifying  the  business
       business  unit  will  provide  business                                                                       rais region of Brazil, with development                             with  what  is  believed  to  be  a  coun-
       development, marketing, sales, logistics,                             Cosucra and DKSH have been part-        fl exibility to supply new markets.                                  ter-cyclical,  accretive  extension  that
       and distribution services for Cosucra’s   Cosucra  utilises  the  properties  of  nering  in  several  countries  in  Europe                    shares in the new merged company for  builds  out  the  company’s  position  as
       range of dietary fi bres and plant-based  two  natural  raw  materials,  chicory  and Asia, including Germany, Switzer-  Under  the  binding  SIA,  Latin  Re-  each  Latin  Resources  share  held,  and  one  of  the  “leading  lithium  materials
       proteins in Australia and New Zealand.  roots and peas, to develop ingredients  land, and the Philippines.    sources shareholders will receive 0.07  will  also  own  about  6.4%  of  Pilbara  suppliers globally”.

       162                                                                    Chemical Weekly  August 27, 2024       Chemical Weekly  August 27, 2024                                                                163


                                      Contents    Index to Advertisers    Index to Products Advertised
   157   158   159   160   161   162   163   164   165   166   167